SARS-CoV-2 Antibody Response and Sustainability after a Third Dose of BNT162b2 in Healthcare Workers at Health Promotion Centers

The aim of this study was to determine the antibody response and the sustainability of immunogenicity after a third dose of BNT162b2 (BNT) in homologous [ChAdOx1 (ChAd)/ChAd, BNT/BNT, and mRNA-1273 (Moderna)/Moderna] and heterologous (ChAd/BNT) vaccinations of two primary doses with different scheme...

Descripción completa

Detalles Bibliográficos
Autores principales: Nah, Eun-Hee, Cho, Seon, Park, Hyeran, Kim, Suyoung, Noh, Dongwon, Kwon, Eunjoo, Cho, Han-Ik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055753/
https://www.ncbi.nlm.nih.gov/pubmed/36992460
http://dx.doi.org/10.3390/v15030751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055753/
https://www.ncbi.nlm.nih.gov/pubmed/36992460
http://dx.doi.org/10.3390/v15030751

Ejemplares similares